Maralixibat (Livmarli)

Status:

Red

Decision Date:

April 2023

Comments

RED: Treatment of cholestatic pruritus in patients with Alagille syndrome aged ≥2 months. 

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again